Cannabis Stock Gainers And Losers From January 4, 2022

© Provided by Benzinga

GAINERS:

Icanic Brands (OTC:ICNAF) shares closed up 16.02% at $0.19 Tetra Bio Pharma (OTC:TBPMF) shares closed up 13.58% at $0.10 Nine Energy Service (NYSE:NINE) shares closed up 12.71% at $1.33 Empower Clinics (OTC:EPWCF) shares closed up 7.05% at $0.29 Village Farms Intl (NASDAQ:VFF) shares closed up 5.99% at $7.08 Sundial Growers (NASDAQ:SNDL) shares closed up 3.57% at $0.64 RIV Capital (OTC:CNPOF) shares closed up 3.45% at $1.20 Heritage Cannabis Holding (OTC:HERTF) shares closed up 3.20% at $0.05

LOSERS:

BioHarvest Sciences (OTC:CNVCF) shares closed down -9.70% at $0.40 cbdMD (AMEX:YCBD) shares closed down -8.33% at $1.10 Rhinomed (OTC:RHNMF) shares closed down -6.68% at $0.20 GrowGeneration (NASDAQ:GRWG) shares closed down -6.59% at $12.90 OrganiGram Holdings (NASDAQ:OGI) shares closed down -6.01% at $1.72 Greenlane Hldgs (NASDAQ:GNLN) shares closed down -5.99% at $0.94 Urban-gro (NASDAQ:UGRO) shares closed down -5.81% at $10.21 EnWave (OTC:NWVCF) shares closed down -5.53% at $0.75 Cannabix Technologies (OTC:BLOZF) shares closed down -4.90% at $0.43 Trulieve Cannabis (OTC:TCNNF) shares closed down -4.87% at $25.41 Green Thumb Industries (OTC:GTBIF) shares closed down -4.63% at $21.62 Neptune Wellness Solns (NASDAQ:NEPT) shares closed down -4.14% at $0.40 World Acceptance (NASDAQ:WRLD) shares closed down -4.13% at $219.86 Innovative Industrial (NYSE:IIPR) shares closed down -3.95% at $239.08 Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed down -3.85% at $0.64 Tilray (NASDAQ:TLRY) shares closed down -3.79% at $7.11 Compass Diversified Hldgs (NYSE:CODI) shares closed down -3.71% at $29.83 TerrAscend (OTC:TRSSF) shares closed down -3.62% at $5.85 HEXO (NASDAQ:HEXO) shares closed down -3.57% at $0.71 Canopy Growth (NASDAQ:CGC) shares closed down -3.55% at $8.97 Alcanna (OTC:LQSIF) shares closed down -3.19% at $5.47 C21 Investments (OTC:CXXIF) shares closed down -3.12% at $0.50

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.